Metacognitive Bibliotherapy for Anxiety, Depression, and Metacognitions in University Students
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-25
SponsorIstanbul Nisantasi University
About this trial
The goal of this clinical trial is to learn if a self-help reading program, called metacognitive bibliotherapy, can reduce anxiety and depression in university students studying medicine and health sciences. It will also examine whether the program changes unhelpful thinking patterns about worry and rumination.
The main questions it aims to answer are:
Does metacognitive bibliotherapy lower anxiety and depression symptoms in university students? Does it reduce unhelpful thinking patterns, such as excessive worry and rumination?
Researchers will compare two different self-help books with a waiting list group to see if reading these books helps reduce anxiety and depression.
Participants will:
* Be randomly assigned to one of three groups: read The Art of Letting Go - How to Stop Rumination, read Anchored: How to Befriend Your Nervous System Using Polyvagal Theory, or join a waiting list * Read the assigned book at their own pace over 8 weeks * Complete online questionnaires at the start of the study, after 4 weeks, and after 8 weeks * Participants in the waiting list group will receive both books for free after the 8-week study period ends
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Active enrollment in the Faculties of Medicine, Nursing, Pharmacy, Dentistry, or Psychology at Istanbul Nisantasi University
Aged between 18 and 25 years
Provision of voluntary digital informed consent
Disqualifiers
Currently receiving active psychiatric treatment (psychotherapy or pharmacotherapy)
Change in psychopharmacological medication within the past 6 months
Prior reading of either of the study books
Presence of acute psychotic symptoms or suicidal risk
Trial design
Design model
Parallel
Treatments tested in this trial
The Art of Letting Go - How to Stop Rumination | Book 1
BehavioralA structured, low-intensity self-help reading program. Participants assigned to Experimental Group 1 receive this self-help book free of charge and read it at their own pace over an 8-week guided bibliotherapy period.
Anchored | Book 2
BehavioralA structured, low-intensity self-help reading program. Participants assigned to Group 2 receive this self-help book free of charge and read it at their own pace over an 8-week guided bibliotherapy period.
Treatment groups
110 Participants
are divided into 3 treatment groupsGroup A: Bibliotherapy - Group 1Experimental treatment 1 intervention
Group B: Waiting List ControlNo intervention 0 interventions
Group C: Bibliotherapy - Group 2Experimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Change in Depression, Anxiety, and Stress Symptoms (DASS-21)
Depression, anxiety, and stress symptom severity will be measured using the Depression Anxiety Stress Scales-21 (DASS-21), a validated self-report instrument. Higher scores indicate greater symptom severity. Change will be assessed across the three measurement points.
Time frame
Baseline (Week 0), mid-intervention (Week 4), and post-intervention (Week 8)2
Change in Metacognitive Beliefs (MCQ-30)
Metacognitive beliefs will be measured using the Metacognitions Questionnaire-30 (MCQ-30), a validated self-report instrument. Higher scores indicate stronger maladaptive metacognitive beliefs. Change will be assessed across the three measurement points.
Time frame
Baseline (Week 0), mid-intervention (Week 4), and post-intervention (Week 8)Secondary outcomes
1
Change in Cognitive Attentional Syndrome (CAS-1)
The Cognitive Attentional Syndrome Scale (CAS-1) will be used to assess perseverative thinking (worry and rumination), threat monitoring, and maladaptive coping strategies. Higher scores indicate greater engagement in the cognitive attentional syndrome. Change will be assessed across the three measurement points.
Time frame
Baseline (Week 0), mid-intervention (Week 4), and post-intervention (Week 8)Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: